(Q48965078)

17 February 2018

title

HIV protease inhibitor ritonavir: a more potent inhibitor of P-glycoprotein than the cyclosporine analog SDZ PSC 833. (English)

1 reference

17 February 2018

1 reference

1 reference

J Drewe

1

1 reference

17 February 2018

H Gutmann

2

1 reference

17 February 2018

G Fricker

3

1 reference

17 February 2018

M Török

4

1 reference

17 February 2018

C Beglinger

5

1 reference

17 February 2018

J Huwyler

6

1 reference

17 February 2018

language of work or name

English

0 references

publication date

1 May 1999

1 reference

17 February 2018

published in

Biochemical Pharmacology

1 reference

17 February 2018

volume

57

1 reference

17 February 2018

issue

10

1 reference

17 February 2018

page(s)

1147-1152

1 reference

17 February 2018

The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900026-X

Seminars in medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900026-X

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900026-X

The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900026-X

Active apical secretory efflux of the HIV protease inhibitors saquinavir and ritonavir in Caco-2 cell monolayers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900026-X

In vitro blood-brain barrier permeability of nevirapine compared to other HIV antiretroviral agents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900026-X

Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavir.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900026-X

Saquinavir pharmacokinetics alone and in combination with ritonavir in HIV-infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900026-X

Pharmacokinetic interactions between two human immunodeficiency virus protease inhibitors, ritonavir and saquinavir

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900026-X

Evidence for P-glycoprotein-modulated penetration of morphine-6-glucuronide into brain capillary endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900026-X

Bovine brain microvessel endothelial cell monolayers as a model system for the blood-brain barrier.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900026-X

Duplication and evolution of the P-glycoprotein genes in pig.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900026-X

Expression of cytochrome P 450 3A enzymes in human lung: a combined RT-PCR and immunohistochemical analysis of normal tissue and lung tumours.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900026-X

HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900026-X

Biochemistry of multidrug resistance mediated by the multidrug transporter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900026-X

Central nervous system as a sanctuary for HIV-1 infection despite treatment with zidovudine, lamivudine and indinavir

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900026-X

10.1016/S0006-2952(99)00026-X

7 January 2021

Identifiers

DOI

1 reference

17 February 2018

PubMed ID

11230802

1 reference

17 February 2018